Evaluating a blood management protocol to reduce transfusions during delivery hemorrhage
Evaluation of the Impact of Implementing a Patient Blood Management Protocol on the Transfusion Rate in Delivery Hemorrhage
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06916832
This study tests if a new blood management plan can help reduce the need for blood transfusions in women who have heavy bleeding during delivery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 240 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer (other) |
| Locations | 1 site (Toulon, VAR) |
| Trial ID | NCT06916832 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the impact of implementing a Patient Blood Management (PBM) protocol on the rate of blood transfusions in women experiencing delivery hemorrhage. Conducted at the Sainte Musse hospital in Toulon, the study will compare data from a retrospective period before the protocol's implementation with a prospective period following its introduction. The PBM protocol includes measures to manage anemia and bleeding, such as screening for anemia and providing iron and vitamin supplementation. The study spans from January 2023 to December 2025.
Who should consider this trial
Good fit: Ideal candidates for this study are women who have experienced delivery hemorrhage, regardless of the mode of delivery.
Not a fit: Patients who are minors, under legal protection, have hemoglobinopathies, or refuse to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the need for blood transfusions during delivery, improving maternal and neonatal outcomes.
How similar studies have performed: Other studies have shown promising results with similar Patient Blood Management approaches, indicating potential for success in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient who has had a delivery hemorrhage, whatever the mode of delivery Exclusion Criteria: * Minor * Under legal protection * Hemoglobinopathies * Patient's refusal to participate in research
Where this trial is running
Toulon, VAR
- Centre Hospitalier Intercommunal de Toulon-La Seyne sur mer — Toulon, VAR, France (RECRUITING)
Study contacts
- Study coordinator: Asmaa JOBIC
- Email: Asmaa.jobic@ch-toulon.fr
- Phone: 04 83 77 20 61
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Delivery Hemorrhage, Delivery hemorrhage, Pregnancy, Blood transfusion, Patient blood management, Iron supplementation, Gestational anemia